Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1994 Sep;71(3):201–206. doi: 10.1136/adc.71.3.201

Growth and metabolic consequences of growth hormone treatment in prepubertal short normal children.

E S McCaughey 1, J Mulligan 1, L D Voss 1, P R Betts 1
PMCID: PMC1029971  PMID: 7979491

Abstract

Growth and the metabolic effects of growth hormone were monitored in a randomised, controlled group of 41 short, normal, prepubertal children. The treated group received daily injections of growth hormone as Genotropin (Kabi Pharmacia) 30 IU/m2/week. Fifteen children in the treated group (21 children) have completed three years of treatment, have grown significantly more than 14 (of 20) untreated children, and have a significantly greater adult height prediction. They do, however, remain leaner (body fat 13.5% in the treated group, 18% in the untreated group) and relatively hyperinsulinaemic (insulin 66.7 pmol/l in the treated group, 44.5 in the untreated group) after three years compared with untreated children. Although growth hormone appears to improve the height potential of prepubertal short normal children, the long term outcome is still uncertain.

Full text

PDF
203

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ackland F. M., Jones J., Buckler J. M., Dunger D. B., Rayner P. H., Preece M. A. Growth hormone treatment in non-growth hormone-deficient children: effects of stopping treatment. Acta Paediatr Scand Suppl. 1990;366:32–37. doi: 10.1111/j.1651-2227.1990.tb11595.x. [DOI] [PubMed] [Google Scholar]
  2. Bourguignon J. P. Growth and timing of puberty: reciprocal effects. Horm Res. 1991;36(3-4):131–135. doi: 10.1159/000182146. [DOI] [PubMed] [Google Scholar]
  3. Brook C. G. Determination of body composition of children from skinfold measurements. Arch Dis Child. 1971 Apr;46(246):182–184. doi: 10.1136/adc.46.246.182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cowell C. T. Effects of growth hormone in short, slowly growing children without growth hormone deficiency. Australasian Paediatric Endocrine Group. Acta Paediatr Scand Suppl. 1990;366:29–31. doi: 10.1111/j.1651-2227.1990.tb11593.x. [DOI] [PubMed] [Google Scholar]
  5. Darendeliler F., Hindmarsh P. C., Preece M. A., Cox L., Brook C. G. Growth hormone increases rate of pubertal maturation. Acta Endocrinol (Copenh) 1990 Mar;122(3):414–416. doi: 10.1530/acta.0.1220414. [DOI] [PubMed] [Google Scholar]
  6. Hindmarsh P. C., Brook C. G. Effect of growth hormone on short normal children. Br Med J (Clin Res Ed) 1987 Sep 5;295(6598):573–577. doi: 10.1136/bmj.295.6598.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hindmarsh P. C., Pringle P. J., Di Silvio L., Brook C. G. Effects of 3 years of growth hormone therapy in short normal children. Acta Paediatr Scand Suppl. 1990;366:6–13. doi: 10.1111/j.1651-2227.1990.tb11587.x. [DOI] [PubMed] [Google Scholar]
  8. Hopwood N. J., Hintz R. L., Gertner J. M., Attie K. M., Johanson A. J., Baptista J., Kuntze J., Blizzard R. M., Cara J. F., Chernausek S. D. Growth response of children with non-growth-hormone deficiency and marked short stature during three years of growth hormone therapy. J Pediatr. 1993 Aug;123(2):215–222. doi: 10.1016/s0022-3476(05)81691-9. [DOI] [PubMed] [Google Scholar]
  9. Johansson G., Sietnieks A., Janssens F., Proesmans W., Vanderschueren-Lodeweyckx M., Holmberg C., Sipilä I., Broyer M., Rappaport R., Albertsson-Wikland K. Recombinant human growth hormone treatment in short children with chronic renal disease, before transplantation or with functioning renal transplants: an interim report on five European studies. Acta Paediatr Scand Suppl. 1990;370:36–43. doi: 10.1111/j.1651-2227.1990.tb11668.x. [DOI] [PubMed] [Google Scholar]
  10. Lesage C., Walker J., Landier F., Chatelain P., Chaussain J. L., Bougnères P. F. Near normalization of adolescent height with growth hormone therapy in very short children without growth hormone deficiency. J Pediatr. 1991 Jul;119(1 Pt 1):29–34. doi: 10.1016/s0022-3476(05)81034-0. [DOI] [PubMed] [Google Scholar]
  11. Moore K. C., Donaldson D. L., Ideus P. L., Gifford R. A., Moore W. V. Clinical diagnoses of children with extremely short stature and their response to growth hormone. J Pediatr. 1993 May;122(5 Pt 1):687–692. doi: 10.1016/s0022-3476(06)80005-3. [DOI] [PubMed] [Google Scholar]
  12. Rabinovitch A., Quigley C., Rechler M. M. Growth hormone stimulates islet B-cell replication in neonatal rat pancreatic monolayer cultures. Diabetes. 1983 Apr;32(4):307–312. doi: 10.2337/diab.32.4.307. [DOI] [PubMed] [Google Scholar]
  13. Ranke M. B., Guilbaud O., Lindberg A., Cole T. Prediction of the growth response in children with various growth disorders treated with growth hormone: analyses of data from the Kabi Pharmacia International Growth Study. International Board of the Kabi Pharmacia International Growth Study. Acta Paediatr Suppl. 1993 Sep;82 (Suppl 391):82–89. doi: 10.1111/j.1651-2227.1993.tb12936.x. [DOI] [PubMed] [Google Scholar]
  14. Rosenfeld R. G., Frane J., Attie K. M., Brasel J. A., Burstein S., Cara J. F., Chernausek S., Gotlin R. W., Kuntze J., Lippe B. M. Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome. J Pediatr. 1992 Jul;121(1):49–55. doi: 10.1016/s0022-3476(05)82540-5. [DOI] [PubMed] [Google Scholar]
  15. SIRI W. E. The gross composition of the body. Adv Biol Med Phys. 1956;4:239–280. doi: 10.1016/b978-1-4832-3110-5.50011-x. [DOI] [PubMed] [Google Scholar]
  16. Stanhope R., Albanese A., Hindmarsh P., Brook C. G. The effects of growth hormone therapy on spontaneous sexual development. Horm Res. 1992;38 (Suppl 1):9–13. doi: 10.1159/000182563. [DOI] [PubMed] [Google Scholar]
  17. Takano K., Hizuka N., Asakawa K., Sukegawa I., Horikawa R., Shizume K. Effects of short-term growth hormone therapy in short children without growth hormone deficiency. Acta Paediatr Scand Suppl. 1990;366:14–23. doi: 10.1111/j.1651-2227.1990.tb11589.x. [DOI] [PubMed] [Google Scholar]
  18. Tanner J. M., Whitehouse R. H., Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. I. Arch Dis Child. 1966 Oct;41(219):454–471. doi: 10.1136/adc.41.219.454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Underwood L. E., Rieser P. A. Is it ethical to treat healthy short children with growth hormone? Acta Paediatr Scand Suppl. 1989;362:18–23. doi: 10.1111/j.1651-2227.1989.tb11302.x. [DOI] [PubMed] [Google Scholar]
  20. Voss L. D., Wilkin T. J., Bailey B. J., Betts P. R. The reliability of height and height velocity in the assessment of growth (the Wessex Growth Study) Arch Dis Child. 1991 Jul;66(7):833–837. doi: 10.1136/adc.66.7.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Walker J. M., Bond S. A., Voss L. D., Betts P. R., Wootton S. A., Jackson A. A. Treatment of short normal children with growth hormone--a cautionary tale? Lancet. 1990 Dec 1;336(8727):1331–1334. doi: 10.1016/0140-6736(90)92891-k. [DOI] [PubMed] [Google Scholar]
  22. Walker J., Chaussain J. L., Bougnères P. F. Growth hormone treatment of children with short stature increases insulin secretion but does not impair glucose disposal. J Clin Endocrinol Metab. 1989 Aug;69(2):253–258. doi: 10.1210/jcem-69-2-253. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES